In addition, to clarify the effect of CXCL16 on ESCs decidualization, decidualised ESCs (ESCs incubated with cAMP plus MPA for 6 days) were then treated with 100 ng/mL recombinant human CXCL16 (rhCXCL16; Cell Signaling Technology), or 5 µg/mL CXCL16 antagonist (anti-CXCL16; Cell Signaling Technology) or the culture supernatants of trophoblast cells, or with culture media of trophoblast (high-glucose DMEM containing 20% v/v FBS), or with vehicle (0.1% v/v dimethyl sulfoxide; Sigma) as control for 3 days. Additionally, the PI3K-AKT signalling pathway inhibitor 10 µM GSK 690693 (Sigma) was added in the past 24 h.
Gsk690693
GSK690693 is a laboratory research product distributed by Merck Group. It is a chemical compound used for research purposes. Further details on the core function or intended use of this product are not available.
Lab products found in correlation
12 protocols using gsk690693
Evaluating CXCL16/CXCR6 Expression in ESCs, DSCs, and Trophoblast Cells
In addition, to clarify the effect of CXCL16 on ESCs decidualization, decidualised ESCs (ESCs incubated with cAMP plus MPA for 6 days) were then treated with 100 ng/mL recombinant human CXCL16 (rhCXCL16; Cell Signaling Technology), or 5 µg/mL CXCL16 antagonist (anti-CXCL16; Cell Signaling Technology) or the culture supernatants of trophoblast cells, or with culture media of trophoblast (high-glucose DMEM containing 20% v/v FBS), or with vehicle (0.1% v/v dimethyl sulfoxide; Sigma) as control for 3 days. Additionally, the PI3K-AKT signalling pathway inhibitor 10 µM GSK 690693 (Sigma) was added in the past 24 h.
Investigating PDGF-BB Signaling Pathways
FOXO3a Relocalisation Assay
CX3CL1 and IL-6 Signaling Pathway Modulators
Inhibition of Pancreatic Cancer Cell Lines
Molecular Mechanisms of 20(S)-GRh2 in Cancer
The primary antibodies against cytochrome c, cleaved caspase-3, Beclin-1, Atg5, cyclin B1, and cyclin D1 and the secondary antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA). β-Actin, Bax, Bal-2, LC3, p-P70S6K, and p-4EBP1 were purchased from the Abcam company (Cambridge, MA, USA). PI3K (p85), Akt, p-Akt (Ser473), mTOR, and p-mTOR (Ser2448) were derived from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The primary antibody against human CD3 was purchased from eBioscience (San Diego, CA, USA).
Cell Culture and Pharmacological Inhibition
Hedgehog Signaling Modulator Assay
The monoclonal Hedgehog neutralizing antibody (5E1, supernatant), developed/deposited by T.M. Jessell/S. Brenner-Morton was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242.
Small Molecule Inhibitor Protocol
Regulatory Signaling Pathway Modulation
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!